Abstract: A compound represented by Chemical Formula 1: wherein in Chemical Formula 1, R1 and R2 are the same or different, and are each independently an electron-withdrawing group, R3 to R6 are the same or different, and are each independently selected from a hydrogen, a substituted or unsubstituted C1 to C20 alkyl group, and a substituted or unsubstituted C6 to C20 aryl group, and n11 and n12 are the same or different, and are each independently an integer from 1 to 4.

Abstract: A composition including a plurality of oligomers including at least one selected from a repeating unit represented by Chemical Formula 1, a repeating unit represented by Chemical Formula 2, and a combination thereof; and at least one selected from a repeating unit represented by Chemical Formula 3, a repeating unit represented by Chemical Formula 3A, and a combination thereof; wherein at least a part of the plurality of oligomers includes at least one terminal end having an amino group, and wherein at least a part of the plurality of oligomers including at least one terminal end having an amino group is a diamine having a pKa value of equal to or less than 3 at 25° C.: wherein the variables in Chemical Formulae 1, 2, 3, and 3A are described in the specification.

Abstract: A poly(imide-amide) copolymer, which is a product of a reaction between a diamine and a dianhydride, wherein the diamine comprises a diamine represented by Chemical Formula 1 and the dianhydride comprises a dianhydride represented by Chemical Formula 5: wherein, the variables in Chemical Formulae 1 and 5 are described in the specification.

Abstract: Disclosed is a polyimide composition including a copolymer including first and/or second repeating unit including an imide repeating unit, or an amic acid repeating unit to form an imide repeating unit through imidization, and a third repeating unit including an amid repeating unit, wherein at least one terminal end of the copolymer is substituted with a substituted or unsubstituted siloxane or silanol group; and an inorganic particle or a precursor thereof.

Abstract: The present invention embraces bis-acridine and bis-quinoline intercalators having a bis(4-aminophenyl)ether tether, and diglycolate salts thereof, for selectively decreasing colon cancer and glial cell proliferation and preventing or treating colon cancers and gliomas.

Abstract: The present invention embraces bis-acridine and bis-quinoline intercalators having a bis(4-aminophenyl)ether tether, and diglycolate salts thereof, for selectively decreasing colon cancer and glial cell proliferation and preventing or treating colon cancers and gliomas.

Abstract: The present invention is a DNA intercalating agent represented by the structure Y—Z—Y, wherein Y is an anti-tumor bis-carbazole and Z is a linear arrangement of multiple aromatic rings, containing at least two aromatic rings, or at least two alicyclic rings, wherein the rings are linked in a 1,4 or 1,3 manner. Methods of inhibiting cancer cells and treating subjects having cancer with these agents are also provided.

Abstract: The present invention is a DNA intercalating agent represented by the structure Y-Z-Y, wherein Y is an anti-tumor bis-carbazole and Z is a linear arrangement of multiple aromatic rings, containing at least two aromatic rings, or at least two alicyclic rings, said rings being linked in a 1,4 or 1,3 manner. Methods of inhibiting cancer cells and treating subjects having cancer with these agents are also provided.